Concentrations of serum pepsinogens (PG) I and II were determined for 3252 randomly selected adults who participated in a population-based gastroscopic screening in an area of China with one of the world’s highest rates of gastric cancer. PG I and II concentrations in both sexes tended to be higher than reported in other countries, with levels generally higher among males than females. PG I tended to decrease and PG II to increase with age, but the most pronounced associations were between PG 1:11 ratios and gastric histology. Median PG 1:11 ratios monotonically declined from 9.1 to 7.2 to 5.7 to 5.4 to 3.8 among those with superficial gastritis, chronic atrophic gastritis, intestinal met-aplasia, dysplasia, and stomach cancer, respectively...
The role of serum PG I in screening patients with chronic atrophic gastritis and gastric cancer, and...
BACKGROUND: Circulating pepsinogens can indicate atrophic gastritis, a precursor of gastric cancer. ...
Artículo científico -- Universidad de Costa Rica. Instituto de Investigaciones en Salud, 2006. Este ...
A low level of serum pepsinogen I (Pg I) is a risk factor for gastric cancer (GC); low levels of Pg ...
Abstract Background The aim of this study is to investigate the difference of serum pepsinogen (PG) ...
The serum pepsinogen (PG) level was determined in 81 patients undergoing gastric examination, and th...
BackgroundPepsinogens (PGs) can be used for gastric cancer (GC) screening, but the cutoff levels var...
Among 7498 Japanese men who were examined from 1967 to 1970, 48 were subsequently diagnosed with sto...
The serum pepsinogen (PG) level was determined in 81 patients undergoing gastric examination, and th...
Chronic atrophic gastritis, which is thought to be a high risk for gastric cancer, can be diagnosed ...
Serum pepsinogens have been widely acknowledged as gastric mucosal biomarkers; however, a multicount...
The correlation between serum pepsinogen (PG) levels and the gross types was investigated in 128 con...
The histological gastric stage (OLGA) plays an important role in evaluating gastric atrophy, a sympt...
In a survey of 930 adults aged 35-74 years randomly sampled from the general population of four area...
The role of serum PG I in screening patients with chronic atrophic gastritis and gastric cancer, and...
The role of serum PG I in screening patients with chronic atrophic gastritis and gastric cancer, and...
BACKGROUND: Circulating pepsinogens can indicate atrophic gastritis, a precursor of gastric cancer. ...
Artículo científico -- Universidad de Costa Rica. Instituto de Investigaciones en Salud, 2006. Este ...
A low level of serum pepsinogen I (Pg I) is a risk factor for gastric cancer (GC); low levels of Pg ...
Abstract Background The aim of this study is to investigate the difference of serum pepsinogen (PG) ...
The serum pepsinogen (PG) level was determined in 81 patients undergoing gastric examination, and th...
BackgroundPepsinogens (PGs) can be used for gastric cancer (GC) screening, but the cutoff levels var...
Among 7498 Japanese men who were examined from 1967 to 1970, 48 were subsequently diagnosed with sto...
The serum pepsinogen (PG) level was determined in 81 patients undergoing gastric examination, and th...
Chronic atrophic gastritis, which is thought to be a high risk for gastric cancer, can be diagnosed ...
Serum pepsinogens have been widely acknowledged as gastric mucosal biomarkers; however, a multicount...
The correlation between serum pepsinogen (PG) levels and the gross types was investigated in 128 con...
The histological gastric stage (OLGA) plays an important role in evaluating gastric atrophy, a sympt...
In a survey of 930 adults aged 35-74 years randomly sampled from the general population of four area...
The role of serum PG I in screening patients with chronic atrophic gastritis and gastric cancer, and...
The role of serum PG I in screening patients with chronic atrophic gastritis and gastric cancer, and...
BACKGROUND: Circulating pepsinogens can indicate atrophic gastritis, a precursor of gastric cancer. ...
Artículo científico -- Universidad de Costa Rica. Instituto de Investigaciones en Salud, 2006. Este ...